116 related articles for article (PubMed ID: 2547747)
1. Azithromycin (CP-62,993) in acute exacerbations of chronic bronchitis: an open clinical, microbiological and pharmacokinetic study.
Davies BI; Maesen FP; Gubbelmans R
J Antimicrob Chemother; 1989 May; 23(5):743-51. PubMed ID: 2547747
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
Cazzola M; Vinciguerra A; Di Perna F; Califano C; Calderaro F; Salzillo A; Centanni S
J Chemother; 1999 Apr; 11(2):119-25. PubMed ID: 10326742
[TBL] [Abstract][Full Text] [Related]
3. Pefloxacin in acute exacerbations of chronic bronchitis.
Maesen FP; Davies BI; Teengs JP
J Antimicrob Chemother; 1985 Sep; 16(3):379-88. PubMed ID: 3863811
[TBL] [Abstract][Full Text] [Related]
4. Aztreonam in patients with acute purulent exacerbations of chronic bronchitis: failure to prevent emergence of pneumococcal infections.
Davies BI; Maesen FP; Teengs JP
J Antimicrob Chemother; 1985 Mar; 15(3):375-84. PubMed ID: 3922936
[TBL] [Abstract][Full Text] [Related]
5. Temafloxacin in acute purulent exacerbations of chronic bronchitis.
Davies BI; Maesen FP; Gubbelmans HL; Cremers HM
J Antimicrob Chemother; 1990 Aug; 26(2):237-46. PubMed ID: 2120178
[TBL] [Abstract][Full Text] [Related]
6. Ceftriaxone in acute purulent exacerbations of chronic bronchitis.
Maesen FP; Davies BI; Teengs JP
J Antimicrob Chemother; 1984 Dec; 14(6):653-60. PubMed ID: 6097574
[TBL] [Abstract][Full Text] [Related]
7. Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitis.
Mertens JC; van Barneveld PW; Asin HR; Ligtvoet E; Visser MR; Branger T; Hoepelman AI
Antimicrob Agents Chemother; 1992 Jul; 36(7):1456-9. PubMed ID: 1324645
[TBL] [Abstract][Full Text] [Related]
8. Clinical and bacteriological experience with cefodizime in acute purulent exacerbations of chronic bronchitis.
Davies BI; Maesen FP; van den Bergh JJ; Costongs RJ; Geraedts WH; Gubbelmans HL; Meek JC
Infection; 1992; 20 Suppl 1():S22-5. PubMed ID: 1526671
[TBL] [Abstract][Full Text] [Related]
9. Latamoxef (moxalactam) in acute exacerbations of chronic bronchitis.
Maesen FP; Davies BI; Brouwers J; Salemans T; Nelissen-Wamper M; Debruyne H
J Antimicrob Chemother; 1983 Feb; 11(2):115-23. PubMed ID: 6219980
[TBL] [Abstract][Full Text] [Related]
10. Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections.
Dark D
Am J Med; 1991 Sep; 91(3A):31S-35S. PubMed ID: 1656740
[TBL] [Abstract][Full Text] [Related]
11. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
Peters DH; Friedel HA; McTavish D
Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis.
Davies BI; Maesen FP; Baur C
Eur J Clin Microbiol; 1986 Apr; 5(2):226-31. PubMed ID: 2941287
[TBL] [Abstract][Full Text] [Related]
13. Is treatment of acute exacerbations of chronic bronchitis with intramuscular mezlocillin justifiable?
Maesen FP; Davies BI; Brouwers J; Salemans T
J Antimicrob Chemother; 1983 Aug; 12(2):169-73. PubMed ID: 6604723
[TBL] [Abstract][Full Text] [Related]
14. The in-vitro activity of CP-62,993 against Haemophilus influenzae, Branhamella catarrhalis, staphylococci and streptococci.
Dunkin KT; Jones S; Howard AJ
J Antimicrob Chemother; 1988 Apr; 21(4):405-11. PubMed ID: 2837451
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerance of erythromycin acistrate in the treatment of acute exacerbations of chronic bronchitis in the elderly.
Forsén KO; Wikberg R; Lehtonen L
Chemotherapy; 1993; 39(6):443-52. PubMed ID: 8222874
[TBL] [Abstract][Full Text] [Related]
16. [New oral quinolone compounds in chronic bronchitis].
Davies BI; Maesen FP; Teengs JP; Baur C
Infection; 1986; 14 Suppl 1():S73-8. PubMed ID: 2937739
[TBL] [Abstract][Full Text] [Related]
17. Erythromycin and bromhexine in acute exacerbations of chronic bronchitis. A study on sputum penetration and clinical effectiveness.
Maesen FP; Davies BI; Brouwers J; Rubingh G
Eur J Respir Dis; 1982 Jul; 63(4):325-9. PubMed ID: 6981522
[TBL] [Abstract][Full Text] [Related]
18. Twice daily dosage of bacampicillin in chronic bronchitis. A double-blind study.
Davies BI; Maesen FP; Brombacher PJ; Sjövall J
Scand J Respir Dis; 1978 Oct; 59(5):249-56. PubMed ID: 32615
[TBL] [Abstract][Full Text] [Related]
19. Ciprofloxacin in acute exacerbations of chronic bronchitis.
Hoogkamp-Korstanje JA; Klein SJ
J Antimicrob Chemother; 1986 Sep; 18(3):407-13. PubMed ID: 3490468
[TBL] [Abstract][Full Text] [Related]
20. Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis.
Cazzola M; Di Perna F; Boveri B; Di Marco F; Diamare F; Centanni S
J Chemother; 2000 Jun; 12(3):216-22. PubMed ID: 10877516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
